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Abstract
A T cell response against myelin basic protein (MBP) is
thought to contribute to the central nervous system (CNS)
inflammation that occurs in the human demyelinating dis-
ease multiple sclerosis. To test whether MBP-reactive T cells
that are normally retrieved from the circulation are capable
of inducing CNS disease, MBP-reactive T cell clones were
isolated from the peripheral blood of healthy, unimmunized
Callithrirjacchus (C.jacchus) marmosets. This primate spe-
cies is characterized by a natural chimerism of bone marrow
elements between siblings that should make possible adop-
tive transfer of MBP-reactive T cells. We report that MBP-
reactive T cell clones efficiently and reproducibly transfer
CNS inflammatory disease between members of C. jacchus
chimeric sets. The demyelination that is characteristic of
experimental allergic encephalomyelitis induced in C. jac-
chus by immunization against human white matter did not
occur after adoptive transfer of the MBP-reactive clones. It
was noteworthy that encephalitogenic T cell clones were
diverse in terms of their recognition of different epitopes of
MBP, distinguishing the response in C. jacehus from that
in some inbred rodents in which restricted recognition of
MBP occurs. These findings are the first direct evidence that
natural populations of circulating T cells directed against
a CNS antigen can mediate an inflammatory autoimmune
disease. (J. Clin. Invest. 1994. 94:1339-1345.) Key words:
experimental allergic encephalomyelitis * multiple sclerosis
* autoinm unity
Introduction
Myelin basic protein (MBP)' is, in most mammalian species,
the major antigen responsible for experimental allergic encepha-
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mental allergic encephalomyelitis; MBP, myelin basic protein; MRI,
magnetic resonance imaging; MS, multiple sclerosis; SI, stimulation
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lomyelitis (EAE), an autoimmune disease which serves as a
model for the human demyelinating disease multiple sclerosis
(MS). In several rodent models, EAE is mediated by a T cell
response to MBP, as demonstrated by the ability of MBP-reac-
tive T cells derived from spleen and lymph nodes of an immu-
nized donor to adoptively transfer disease into naive syngeneic
recipients ( 1-4). In humans, MBP-reactive T cells are thought
to play a role in acute disseminated encephalomyelitis that fol-
lows infection or vaccination (5, 6) and have long been sus-
pected as effector cells in MS (7). MBP-reactive T cells are
present in the circulation of patients with MS but are also pres-
ent in healthy individuals (8-12). The role of these circulating
T cell populations in the induction of human MS is unknown.
Cross-species adoptive transfer experiments have been at-
tempted with human donor cells transferred into rodent hosts,
but have been unsuccessful (N. Joshi, unpublished observa-
tions) or have yielded uncertain results (13-15).
The common marmoset Callithrixjacchus (C. jacchus) rep-
resents a unique species for the study of T cell-mediated dis-
eases in primates, because these monkeys are born as naturally
occurring bone marrow chimeras. While the individual animals
arise from separate ova that are fertilized independently, the
placentas of the developing animals fuse, resulting in a crosscir-
culation of bone marrow-derived elements between the fetuses.
Thus, while the animals are genetically distinct, they share, and
are tolerant to, each other's bone marrow-derived cell popula-
tions (16). The natural chimerism in C. jacchus theoretically
makes possible adoptive transfer of functional T cell popula-
tions between members of an outbred species without initiating
an alloresponse. We have recently found that a relapsing-remit-
ting form ofEAE which bears a strong clinical and pathological
resemblance to human MS can be induced in C. jacchus by
immunization with human CNS white matter.2 Immunized ani-
mals display specific proliferative responses to MBP, suggesting
that MBP is an autoantigen in C. jacchus EAE. Thus, this
outbred species of non-human primate is characterized by bone
marrow chimerism and susceptibility to CNS disease, creating
an opportunity to elucidate the antigenic repertoire and the en-
cephalitogenic potential of circulating populations of MBP-re-
active T cells.
Here we show that MBP-reactive T cell clones can be de-
rived from the circulation of unimmunized, healthy C. jacchus.
Furthermore, these T cell clones are consistently able to induce
an inflammatory CNS disease by adoptive transfer. Different T
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cell clones derived from the same animal and reactive against
different epitopes of MBP appear to be equally encephalito-
genic. The data are the first direct demonstration that T cells
reactive against a self-antigen and present in the normal circulat-
ing pool are capable of mediating an autoimmune disease.
Methods
Animals. C. jacchus marmosets were maintained in primate colonies at
the University of California, San Francisco and New England Regional
Primate Research Center. The animals used in this study were cared for
in accordance with the guidelines of the Committee on Animals of the
Harvard Medical School and those of the Committee on Care and Use
of Laboratory Animals of the Institute of Laboratory Animal Resources,
National Research Council. A maximum of 2.5 ml of blood every other
week was taken from each animal. CSF was obtained by puncture of
the cisterna magna. Phlebotomy, cisternal puncture, and intravenous
transfer of T cells were done under brief anesthesia (Ketamine, 10
mg i.m.). Magnetic resonance imaging (MRI) was performed under
anesthesia with Propofol, 20-50 mg/h in intravenous drip.
Production and characterization of T cell clones. MBP-reactive T
cell clones were derived from PBMC of naive (e.g., unimmunized) C.
jacchus by limiting dilution. Freshly isolated PBMC were cultured at
105 cells/well in 96 round-bottom well plates (Corning Inc., Corning,
NY) with purified human MBP (50 pg/ml final concentration) (17) in
RPMI 1640 supplemented with 2 mM glutamine (Gibco, Grand Island,
NY), 20 mM Hepes buffer and 10% controlled processed serum replace-
ment-2 (CPSR-2) (Sigma Chemical Co., St. Louis, MO), and penicillin/
streptomycin/gentamycin at standard concentrations (Gibco). After 3
d the culture medium was supplemented with 10% heat-inactivated
human AB serum (Pel-Freez Biologicals, Rogers, AR), 10% human T
cell growth factor (Cellular Prods. Inc., Buffalo, NY), 40 U/ml recom-
binant IL-2 (Hazelton Systems, Inc., Aberdeen, MD) and 4 U/mI IL-4
(Genzyme Corp., Cambridge, MA) and this growth medium was
changed every 3 d for 9 d. T cells were restimulated at the end of the
cycle by addition of 105 syngeneic and/or chimeric freshly isolated
PBMC pulsed with MBP (50 Htg/ml) and irradiated (3000 rad) as APC.
T cell clones were expanded by multiple cycles of restimulation with
MBP/APC followed by culture in growth medium. After 4-6 cycles,
MBP-reactive clones were identified and characterized for peptide speci-
ficity by [3H]thymidine incorporation in a 72-h proliferation assay. 5
x 104 T cells were cultured with i0' irradiated APC and 25 tig/ml of
MBP, 50 ttg/ml of each MBP-peptide or no antigen (background) in
10% CPSR-2 medium for 72 h. 18 h before termination, [3H]thymidine
(0.5 tiCi/well) was added. The stimulation index (SI) was measured
for each MBP-reactive clone on the day of transfer and was calculated
as the ratio of incorporation of [3H]thymidine (cpm) in the presence
of MBP over that of background. Fine mapping of peptide reactivity
was studied using a panel of sixteen 20-mer synthetic peptides corre-
sponding to overlapping peptides of human MBP. Human and monkey
MBP differ by only 4 of 172 amino acids ( 18). All peptides recognized
by the MBP-reactive T cell clones shared sequence identity with monkey
MBP, with the exception of one clone directed against the human 143-
162 amino acid sequence that differs by a single amino acid between
the species. T cell clones used in control experiments were isolated by
the same limiting dilution technique but did not react with MBP or
peptides in the proliferation assay.
Adoptive transfer. At the end of the stimulation cycle 107 T cells
were rested for 48 h in CPSR-2 medium, then restimulated with either:
MBP (50 4g/ml) in the presence of irradiated (3000 rad) syngeneic/
chimeric PBMC as APC; or 4 og/ml concanavalin A. Control, MBP
nonreactive clones were restimulated with 4 jsg/ml concanavalin A.
Growth medium was added after 48 h, and 24 h later cells were har-
vested, washed with RPMI, resuspended in 2 ml of 0.9% saline i.v. and
injected into the popliteal vein, followed immediately by intravenous
injection of 100 killed Bordetella pertussis organisms. 48 h later, a
second intravenous injection of Bordetella pertussis was administered.
In an additional control group, two animals received the two injections
of Bordetella pertussis but no cells.
Table 1. Effective Cross-presentation of MBP and the Synthetic
Peptide 153-172 to the T cell Clone 31.N.2.73 by APC from
Chimeric Siblings
cpm (SI)
Animal source MBP aa 153-172
of APC Background (25 yg/ml) (50 /g/ml)
A* 1,350 15,159 (8.8) 14,761 (9.1)
1,887 13,498
B 2,107 13,531 (6.2) 13,112 (5.8)
2,427 14,943
C 654 11,835 (17) 15,239 (23)
679 10,954
Clone 31.N.2.73 was derived from animal A (*) in chimeric set 3 (see
Table II).
Assessment ofEAE. The appearance of EAE was monitored in recip-
ient animals by daily clinical evaluation, examination of CSF, MRI, and
neuropathologic criteria. The severity of disease was graded by two
independent observers blinded as to the identity of the clone transferred:
0, normal; 1, lethargy, anorexia, weight loss; 2, ataxia and either parapa-
resis/monoparesis, sensory loss or brain stem syndrome including gaze
palsy, blindness or dysarthria; 3, paraplegia or hemiplegia; 4, quadriple-
gia. Postmortem examination was performed on formalin-fixed tissues.
Results
Adoptive transfer of EAE by natural MBP-reactive T cell
clones. We first demonstrated that APC from chimeric siblings
were equivalent to syngeneic APC in the presentation of MBP
or the relevant peptide to the T cell clones derived from one
member of the sets (Table I). Therefore, selected clones could
be adoptively transferred into the animal of origin or into a
chimeric sibling. Table II summarizes the results for five adop-
tive transfers performed with MBP-reactive clones, and three
control adoptive transfers carried out with MBP nonreactive
clones (chimeric sets 1-4). In chimeric set 5, animals received
intravenous Bordetella pertussis but no cells. The SI of the
different MBP-reactive clones used for adoptive transfers
ranged from 6 to 215. No reactivity to MBP (SI < 1) was
detected in the control clones. Clinical signs of EAE developed
within 13-27 d after T cell transfer in all five C. jacchus that
received an MBP-reactive T cell clone (chimeric set 1, animals
A and B; chimeric set 2, animal A; chimeric set 3, animals A
and B), and in no control animal. Signs included weight loss,
sensory loss in the lower limbs, tremor, mono- or paraparesis,
or a brain stem syndrome consisting of an altered cry and disor-
dered conjugate gaze. Disease severity did not exceed grade 2
(Table II). In two animals not killed, clinical signs persisted
for a period of 4-8 wk before gradually disappearing (animals
A and B, chimeric set 3). In one experiment (chimeric set 3,
clone 31.N.2.73), concanavalin A appeared as efficient as MBP
for stimulation of the encephalitogenic clone prior to transfer.
In each animal with EAE, cerebrospinal fluid (CSF) pleocytosis
indicative of central nervous system (CNS) inflammatory dis-
ease was present at the onset of clinical signs (Table II). Se-
quential CSF analyses performed in two animals (chimeric set
3) indicated that pleocytosis preceded the onset of neurologic
signs (Fig. 1). In the same two animals, MRI studies were
performed after the onset of the neurologic signs. Foci of in-
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Table I. Adoptive Transfer ofEAE by Naturally Occurring MBP- reactive T Cell Clones
Chimeric No. of cells Clone No. and
set Animal transferred specificity SI Onset Clinical signs (EAE grade) CSF Pathology
d after transfer WBC/mm3
1 A 107 24.N.2.14 52 13 Extraocular motor palsy, 750
aa 153-172$ dysarthria euthanized day 20
(2)
B* 107 24.N.2.7 215 14 Paraparesis and sensory loss 60 +
aa 11 -30* lower limbs: euthanized day
20 (2)
C 107 24.N.2.5 - (48 d observation) None: euthanized day 48 (0) 9
Nonreactive'
2 A 107 21.N.2.26 21 13 Paraparesis, tremor; euthanized 360 +
aa 143-162* day 22 (2)
B 107 21.N.2.23 (94 d observation) None (0) 0 ND
Nonreactive5
3 A* 107 31.N.2.73 8.8 14 Complete sensory loss lower 75 ND
aa 153-172* limbs (2)
B 107 31.N.2.73 6.3 27 Left lower leg weakness (2) 465 ND
aa 153-172'
C ND
4 A* 107 6.N.2.0 (270 d observation) None (0) 0 ND-
Nonreactive'
5 A i.v. pertussis - (72 d observation) None (0) 0 ND
B i.v. pertussis (48 d observation) None (0) ND ND
* Origin of MBP-reactive T cell clones and control, non-MBP reactive clones used for transfer, e.g., animal B, chimeric set 1; animal C, chimeric
set 2 (not shown); animal A, chimeric set 3; animal A, chimeric set 4. Stimulation of T cell clones prior to transfer was performed with either
MBP (*) or concanavalin A (I). MPB-reactive T cell clones in chimeric sets 1 and 2 were stimulated with MBP. In chimeric set 3, two adoptive
transfer were performed with the same clone (31.N.2.73) stimulated with either MBP (animal A) or concanavalin A (animal B). All control, non
MBP-reactive clones were stimulated with concanavalin A. ND, Not done.
creased signal intensity on T2-weighted images were present,
suggestive of edema (Fig. 2A). On Ti-weighted images, ob-
tained following administration of contrast material, areas of
gadolinium enhancement appeared in CNS white matter, indica-
tive of blood brain barrier breakdown (Fig. 2, B and C). Some
of the MRI findings in the animals studied correlated with the
clinical signs. For example, animal B displayed left lower limb
weakness and a lesion within the right side of the midbrain.
Animal A had sensory loss in the lower limbs and evidence of
a lesion with mass effect in the posterior column of the cervical
cord (Table II and Fig. 2, B and C). Control animals were
observed for a period ranging between 48 and 270 d. None of
the five C. jacchus in this group developed clinical signs of
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EAE. CSF studies performed at day 14 and 28 after transfer
were normal (Table II).
Postmortem examination of the cerebrum and the spinal cord
was performed in three animals with EAE and in one control
animal. The animals with EAE were killed between day 20 and
day 22 after adoptive transfer of T cell clones, corresponding to
6-9 d after the onset of the clinical signs (Table II). At this stage
of disease, occasional areas of necrosis and inflammation were
present in two of the diseased animals (Table II, Fig. 2D), but
foci of demyelination and gliosis were notably absent. No lesion
was observed in the control animal studied.
Antigenic repertoire of natural encephalitogenic T cell
clones. The frequency of MBP-reactive T cell clones in circulat-
3
-4<
IA , Figure 1. CSF pleocytosis precedes the onset ofI clinical signs in adoptive EAE. Two animals
were studied by sequential cisternal puncture and
O clinical examination. For each, the CSF cell
'0;I count (circle) and corresponding clinical score
40 (triangle) is shown in relation to the time of
adoptive transfer.
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Figure 2. MRI and Pathologic Findings in adoptive EAE. (A) A focus of increased T2 signal intensity appears in the left temporal-parietal white
matter (1) and mass effect from a second lesion produces thinning of the left splenium of the corpus callosum (2); (B) A Ti scan following
intravenous administration of Gadolinium-DTPA demonstrates an enhancing lesion within the right side of the midbrain (arrow); chimeric set 3,
animal B. (C) Cervical cord section demonstrates a Ti-Gadolinium enhancing lesion in the right posterior column (arrow) with mass effect on
the posterior horn of the gray matter of the cord; chimeric set 3, animal A. (D) Pathological example of a necrotic focus without demyelination in
the dorsal mesencephalon. Frozen section. (Hematoxylin/eosin, x300); chimeric set 2, animal A.
ing PBMC of normal C. jacchus ranged between 3 and 7 per
lo-, similar to the frequency estimated to be present in the
circulation of healthy humans (8-12). Mapping of the antigenic
peptides recognized by individual clones indicated that multiple
regions of the MBP molecule were recognized by naturally
occurring T cells (Fig. 3). The pattern of reactivity to overlap-
ping peptides identified differences in the fine specificity be-
tween clones reactive against similar regions of MBP, further
increasing the number of epitopes recognized. For example, the
fine specificity of aminoterminus-reactive clones 31N.2.18 and
31.N.2.54 could be distinguished by reactivity against aa 1-21
in the former clone only (Fig. 3). Similarly, encephalitogenicity
in the blood-derived T cell clones was not restricted by recogni-
tion of a single antigenic region of MBP. Four clones, each
reactive against one of three different fragments of the molecule
(aa 11-30, 143-162, and 153-172), could efficiently transfer
disease (Table II). In chimeric set 1, two different clones de-
rived from the same animal, reactive respectively against the
amino terminus and carboxyl terminus regions of MBP, were
encephalitogenic. These data indicate diversity in the T cell
response to MBP that may result in clinical disease.
Discussion
MBP-reactive T cells could readily be cloned from the periph-
eral blood of normal unimmunized C. jacchus primates. They
were similar in several respects to the repertoire of circulating
MBP-reactive cells described in human blood (8-12). First,
circulating MBP-reactive T cells occur at similar frequencies
in the two species. Second, fine specificity mapping of different
T cell clones derived from single individuals indicated diversity
of recognition to multiple different epitopes of MBP. Thus, both
in C. jacchus and human primate PBMC, a high fiequency of
MBP-reactive T cells and diversity in MBP epitope recognition
are characteristic.
The bone marrow chimerism in C. jacchus made possible
the direct demonstration that MBP-reactive T cells were enceph-
alitogenic following expansion and adoptive transfer. Thus, po-
tential disease-inducing populations of MBP-reactive T cells
are normally present in primates. In rats, Schluesener and Wek-
erle were able to isolate a single encephalitogenic MBP-reactive
T cell line from lymph node of the EAE susceptible Lewis
strain, but a similar line derived from the resistant BN strain
was nonencephalitogenic (19). The Lewis line was successfully
derived only after multiple negative attempts, and following
negative selection of autologous MHC-reactive T cells. This
was the first demonstration that EAE-inducing populations are
present in the normal immune system. The current data demon-
strate that these cells are in relative abundance in the circulation
of normal outbred primates and are diverse in terms of their
recognition of different epitopes of MBP. In C. jacchus, MBP-
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Figure 3. The natural repertoire of circulating MBP-reactive T cells in a healthy C. jacchus marmoset. Each clone was mapped for reactivity
against synthetic 20-mer peptides corresponding to overlapping regions of human MBP. In this animal (chimeric set 3, animal A) at least seven
discrete epitopes of MBP were recognized by different T cell clones.
reactive T cells are neither deleted, nor irreversibly tolerized,
in the peripheral pool.
What mechanisms prevent development of spontaneous
EAE in C. jacchus? MBP-reactive T cells must first penetrate
the blood-brain barrier to mediate disease, a process that is
influenced by activation (20). Activation by specific antigen, a
relevant superantigen (21) or a mitogen (4), could enhance
CNS migration of naturally occurring circulating encephalito-
genic T cells. The critical role of environmental exposure on
the course ofEAE was illustrated recently in a transgenic mouse
model. A functional T cell receptor derived from an encephalito-
genic MBP-reactive T cell was expressed in an MHC compati-
ble host (22). All peripheral immune system CD4 cells ex-
pressed the transgenic T cell receptor. Surprisingly, develop-
ment of EAE in these animals required additional exposure
to environmental pathogens or immunization with Bordetella
pertussis. Transgenic animals unimmunized or housed in a
germ-free environment did not spontaneously develop EAE.
Thus, a large burden of encephalitogenic T cells may be toler-
ated under some conditions without pathogenic consequences
to the host. This appears also to be the case in C. jacchus. It
is possible that active suppression might inhibit spontaneous
induction of EAE by natural encephalitogenic T cell popula-
tions. In Lewis rats tolerized with CNS antigens (23) or recov-
ered from EAE, suppressor T cell lines have been isolated that
are capable of preventing EAE after adoptive transfer of enceph-
alitogenic T cell lines (reviewed in 24). In H-2U mice, recovery
from MBP-induced EAE is associated with expansion of a CD4
T cell population that expresses the V,614 T cell receptor gene
segment and responds to a V,98.2 peptide expressed on most
MBP-reactive encephalitogenic T cells in this strain (25).
Mapping data in C. jacchus are in agreement with a previous
report suggesting that the carboxy terminus of MBP contains
antigenic determinants in primates (26) but also indicates that
the natural encephalitogenic repertoire in C. jacchus is broad.
In most inbred rodents examined, only exceedingly restricted
populations of T cells mediate acute EAE. For example, the
encephalitogenic response to MBP is largely directed against
the 1-9 amino terminus in the H-2U mouse, against several
epitopes within the 89-101 fragment in H-2S mouse, and
against the 68-88 fragment in the Lewis rat (27-29). Similar
to C. jacchus, diversity in recognition of MBP peptides appears
to be characteristic of healthy humans and also patients with
multiple sclerosis (MS) (8, 9, 12, 30-33). In outbred primates,
both human and nonhuman, heterozygosity at different loci of
the MHC may contribute to effective recognition of a greater
number of epitopes of MBP than is possible in inbred rodents.
Based upon analogy with C. jacchus, it is likely that, in humans,
T cells that recognize diverse epitopes of MBP are potentially
encephalitogenic. This concept has important implications for
future attempts to specifically modulate an autoimmune re-
sponse to MBP in humans.
Prominent and early demyelination is a hallmark of acute
EAE induced in C. jacchus by active immunization with whole
human white matter in adjuvant.2 Following adoptive transfer
to naive recipients, MBP-reactive T cells induced clinical signs,
inflammation in the CSF, and multifocal areas of disruption of
the blood-brain barrier on MRI scans. In contrast, however, to
the active immunization model, disease severity was mild and
demyelination was conspicuously absent in adoptive transfer
recipients. This indicates that, in C. jacchus, MBP-reactive T
cells are capable of inducing CNS inflammation and clinical
signs, but are not sufficient for plaque formation. In the active
immunization model of EAE, early and intense macrophage
infiltration occurs within lesions2 and these cells appear to medi-
ate the characteristic demyelination that occurs. This macro-
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phage response was not noted following adoptive transfer by
MBP-reactive T cells. It is possible that, in synergy with a T
cell response to MBP, autoantibodies are required for demyelin-
ation to occur in C. jacchus. In addition to T cells, a corequire-
ment for antibodies in the pathogenesis of demyelination is
present in rabbits (34), guinea pigs (35) and rats (36, 37). It
is also likely that, in addition to MBP, other CNS antigens are
relevant to EAE in C. jacchus, as active immunization with
purified human MBP in adjuvant results in a nondemyelinating
form of EAE similar to that following adoptive transfer (C.
Genain and S. L. Hauser, unpublished observations).
Based upon the finding that primary immune responses to
some antigens are not efficiently generated within the CNS, it
has long been postulated that the nervous system is immunologi-
cally privileged. Relative isolation of the nervous system from
the immune system might result in failure to tolerize T cells to
CNS antigens, in contrast to antigens expressed in other organs
of the body. Naturally occurring autoimmune T cells may exist
that mediate encephalomyelitis but not disease in other organ
systems. Alternatively, T cells capable of inducing inflamma-
tory disease in many different organs may be generally present
in the circulation of primates. In contrast to humans and nonhu-
man primates, in which naturally occurring MBP-reactive
PBMC are present (8, 9, 12, 30-33, 38), we are unaware of
any successful identification of MBP-reactive T cells in the
circulation of rodents. The C. jacchus marmoset is thus remark-
able for circulating autoreactive T cells, close phylogeneic simi-
larity to humans, and natural chimerism of bone marrow derived
elements, all features unique to this model. These characteristics
create an opportunity to study the regulation, traffic, and fate
of disease-inducing T cells in normal primate homeostasis.
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